Staff Publications: May 2016

1. Adams DL, Adams DK, Alpaugh RK, et al. Circulating Cancer Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions. Cancer Epidemiol Biomarkers Prev. 2016.

2. Adams DL, Adams DK, Stefansson S, et al. Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas. Breast Cancer Res. 2016;18(1):44.

3. Alexander J, Cukierman E. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. Curr Opin Cell Biol. 2016;42:80-93.

4. Allen JI, Weinberg DS. Update in Gastroenterology and Hepatology: Evidence Published in 2015. Annals of Internal Medicine. 2016;164(9):W21-W26.

5. Basaran K, Basat SO, Ozel A, et al. The Effects of Mucoperichondrial Flap Elevation on Septal L-Strut Cartilage: A Biomechanical and Histologic Analysis in a Rabbit Model. Plast Reconstr Surg. 2016;137(6):1784-1791.

6. Beringer LT, Kiechel MA, Komiya Y, et al. Osteoblast biocompatibility of novel chitosan crosslinker, hexamethylene-1,6-diaminocarboxysulfonate. J Biomed Mater Res A. 2015;103(9):3026-3033.

7. Campbell KS. Suppressing the killer instinct. Sci Signal. 2016;9(429):fs8.

8. Campbell SC, Gupta GN, Uzzo RG, Kutikov A. Re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped “Minimal-margin” Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12. European Urology. 2016;69(5):E95-E96.

9. Carroll PR, Parsons JK, Andriole G, et al. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016;14(5):509-519.

10. Chesney TR, Nadler A, Acuna SA, Swallow CJ. Outcomes of resection for locoregionally recurrent colon cancer: A systematic review. Surgery. 2016.

11. Choueiri TK, Fishman M, Escudier B, et al. Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2016.

12. Coit DG, Thompson JA, Algazi A, et al. Melanoma, version 2.2016 clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2016;14(4):450-473.

13. Darlow SD, Heckman CJ, Munshi T, Collins BN. Thirdhand smoke beliefs and behaviors among healthcare professionals. Psychol Health Med. 2016:1-10.
14. Flannery M, Mohile SG, Dale W, et al. Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI. J Geriatr Oncol. 2016.

15. George S, Motzer RJ, Hammers HJ, et al. Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial. JAMA Oncol. 2016.

16. Geynisman DM, Plimack ER, Zibelman M. Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early? Eur Urol. 2016.

17. Hedges SB, Marin J, Suleski M, Paymer M, Kumar S. Tree of life reveals clock-like speciation and diversification. Mol Biol Evol. 2015;32(4):835-845.

18. Huwe PJ, Xu Q, Shapovalov MV, Modi V, Andrake MD, Dunbrack RL. Biological function derived from predicted structures in CASP11. Proteins. 2016.

19. Kiechel MA, Beringer LT, Donius AE, et al. Osteoblast biocompatibility of premineralized, hexamethylene-1,6-diaminocarboxysulfonate crosslinked chitosan fibers. J Biomed Mater Res A. 2015;103(10):3201-3211.

20. Kinczewski L. Microwave Ablation for Palliation of Bone Metastases. Clin J Oncol Nurs. 2016;20(3):249-252.

21. Knezevic T, Myers VD, Gordon J, et al. BAG3: a new player in the heart failure paradigm. Heart Fail Rev. 2015;20(4):423-434.

22. Li H, Feng B, Miron A, et al. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab. Genet Med. 2016.

23. Li JQ, Handorf E, Bekelman J, Mitra N. Propensity score and doubly robust methods for estimating the effect of treatment on censored cost. Statistics in Medicine. 2016;35(12):1985-1999.

24. Lounsbury N, Mateo G, Jones B, et al. Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy. Bioorg Med Chem. 2015;23(17):5352-5359.

25. Lubet RA, Townsend R, Clapper ML, et al. 5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target? Cancer Prev Res (Phila). 2016.

26. McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C. Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. Clin Imaging. 2016;40(5):936-943.

27. Michael JV, Wurtzel JG, Goldfinger LE. Regulation of H-Ras-driven MAPK signaling, transformation and tumorigenesis, but not PI3K signaling and tumor progression, by plasma membrane microdomains. Oncogenesis. 2016;5(5):e228.

28. Mochizuki K, Meng L, Mochizuki I, et al. Programming of donor T cells using allogeneic delta-like ligand 4-positive dendritic cells to reduce GVHD in mice. Blood. 2016.
29. Monk BJ, Sill MW, Walker JL, et al. Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2016.

30. Montgomery DC, Garlick JM, Kulkarni RA, et al. Global Profiling of Acetyltransferase Feedback Regulation. J Am Chem Soc. 2016;138(20):6388-6391.
31. Muro K, Chung HC, Shankaran V, et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol. 2016.

32. Murphy CT, Galloway TJ, Handorf EA, et al. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. J Clin Oncol. 2016;34(2):169-178.

33. Plimack ER, Geynisman DM. Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress. J Clin Oncol. 2016.
34. Pogash TJ, El-Bayoumy K, Amin S, et al. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. In Vitro Cell Dev Biol Anim. 2015;51(2):121-127.

35. Presley CJ, Dotan E, Soto-Perez-de-Celis E, et al. Gaps in nutritional research among older adults with cancer. J Geriatr Oncol. 2016.

36. Rao S, Cai KQ, Stadanlick JE, et al. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma. Cancer Res. 2016;76(11):3387-3396.

37. Rawat SJ, Araiza-Olivera D, Arias-Romero LE, et al. H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization. Curr Biol. 2016.

38. Reese JB, Haythornthwaite JA. Importance of sexuality in colorectal cancer: predictors, changes, and response to an intimacy enhancement intervention. Support Care Cancer. 2016.

39. Ridge J. A Century of Progress: Our 100th Anniversary Proceedings of the 98th Annual Meeting of the American Radium Society. Oncology-New York. 2016;30:V-VI.

40. Rowley JW, Chappaz S, Corduan A, et al. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood. 2016;127(14):1743-1751.

41. Seeger C, Sohn JA. Complete spectrum of CRISPR/Cas9-induced mutations on HBV cccDNA. Mol Ther. 2016.

42. Shaikh T, Churilla T, Murphy C, et al. 97O: Overtreatment of patients with clinically diagnosed early stage lung cancer. J Thorac Oncol. 2016;11(4 Suppl):S99.

43. Sorscher SM, Pilarski R, Daly M. Correspondence. J Natl Compr Canc Netw. 2016;14(5):l-li.

44. Stabler CT, Lecht S, Mondrinos MJ, Goulart E, Lazarovici P, Lelkes PI. Revascularization of decellularized lung scaffolds: principles and progress. Am J Physiol Lung Cell Mol Physiol. 2015;309(11):L1273-1285.

45. Tan CRC, Zhou L, El-Deiry WS. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons. Current Colorectal Cancer Reports. 2016;12(3):151-161.

46. Tanaka K, Whelan KA, Chandramouleeswaran PM, et al. ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds. Am J Cancer Res. 2016;6(4):781-796.

47. Tsueng G, Good BM, Ping P, et al. Gene Wiki Reviews-Raising the quality and accessibility of information about the human genome. Gene. 2016.

48. Volokh OI, Hsieh FK, Karlova MG, Trifonova ES, Studitsky VM, Sokolova OS. Study of RNA polymerase transcription through nucleosome using the cryo-electron microscopy approach. Moscow University Biological Sciences Bulletin. 2016;71(1):34-38.

49. Wagner AJ, Agulnik M, Heinrich MC, et al. Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. Eur J Cancer. 2016;61:94-101.

50. Wang Y, Bernhardy AJ, Cruz C, et al. The BRCA1-Delta11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. Cancer Res. 2016;76(9):2778-2790.

51. Xu KY, Shameem R, Wu S. Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysis. Acta Oncol. 2016:1-8.

52. Zahid MF, Khan N, Pei J, Testa JR, Dulaimi E. Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia. Leukemia Research Reports. 2016;5:23-26.

53. Zhang H, Chang YC, Huang Q, Brennan ML, Wu J. Structural and Functional Analysis of a Talin Triple-Domain Module Suggests an Alternative Talin Autoinhibitory Configuration. Structure. 2016;24(5):721-729.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s